MAFD2
MCID: MJR008
MIFTS: 35

Major Affective Disorder 2 (MAFD2)

Categories: Genetic diseases, Mental diseases

Aliases & Classifications for Major Affective Disorder 2

MalaCards integrated aliases for Major Affective Disorder 2:

Name: Major Affective Disorder 2 57 12 13 72
Manic-Depressive Psychosis, X-Linked; Mdx 57
Manic-Depressive Psychosis, X-Linked 57
Bipolar Affective Disorder; Bpad 57
Manic-Depressive Illness; Mdi 57
Bipolar Affective Disorder 57
Manic-Depressive Illness 57
Bipolar Disorder 72
Mafd2 57
Bpad 57
Mdi 57
Mdx 57

Characteristics:

OMIM:

57
Inheritance:
? x-linked dominant vs. multifactorial


HPO:

32
major affective disorder 2:
Onset and clinical course infantile onset
Inheritance x-linked dominant inheritance


Classifications:



External Ids:

Disease Ontology 12 DOID:0080221
OMIM 57 309200
MedGen 42 C1839839
UMLS 72 C0005586 C1839839

Summaries for Major Affective Disorder 2

MalaCards based summary : Major Affective Disorder 2, also known as manic-depressive psychosis, x-linked; mdx, is related to major affective disorder 1 and major affective disorder 5. An important gene associated with Major Affective Disorder 2 is MAFD2 (Major Affective Disorder 2). The drugs Paroxetine and Sertraline have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and eye, and related phenotype is bipolar affective disorder.

More information from OMIM: 309200

Related Diseases for Major Affective Disorder 2

Diseases in the Major Affective Disorder 1 family:

Major Affective Disorder 2 Major Affective Disorder 3
Major Affective Disorder 4 Major Affective Disorder 5
Major Affective Disorder 6 Major Affective Disorder 8
Major Affective Disorder 7 Major Affective Disorder 9

Diseases related to Major Affective Disorder 2 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 320)
# Related Disease Score Top Affiliating Genes
1 major affective disorder 1 12.1
2 major affective disorder 5 12.1
3 major affective disorder 6 12.1
4 major affective disorder 8 11.9
5 major affective disorder 9 11.9
6 major affective disorder 4 11.8
7 major affective disorder 3 11.6
8 major affective disorder 7 11.5
9 bipolar disorder 11.5
10 muscular dystrophy 11.4
11 muscular dystrophy, duchenne type 11.4
12 diabetes mellitus, permanent neonatal 11.3
13 diphenylmethane-4,4'-diisocyanate allergic asthma 11.2
14 diphenylmethane-4,4'-diisocyanate allergic contact dermatitis 11.2
15 muscular atrophy 10.9
16 myopathy 10.8
17 dystrophinopathies 10.8
18 gas gangrene 10.7
19 mood disorder 10.7
20 qualitative or quantitative defects of dystrophin 10.7
21 neuromuscular disease 10.6
22 atrial standstill 1 10.6
23 endogenous depression 10.5
24 muscular dystrophy, becker type 10.5
25 schizophrenia 10.5
26 hypoglycemia 10.5
27 respiratory failure 10.5
28 dilated cardiomyopathy 10.5
29 allergic hypersensitivity disease 10.5
30 depression 10.5
31 mental depression 10.5
32 yemenite deaf-blind hypopigmentation syndrome 10.5
33 color blindness 10.5
34 muscle hypertrophy 10.4
35 bipolar i disorder 10.4
36 asthma 10.4
37 extrinsic allergic alveolitis 10.4
38 color vision deficiency 10.4
39 tetanus 10.4
40 major depressive disorder 10.4
41 insulin-like growth factor i 10.4
42 skeletal muscle disease 10.4
43 personality disorder 10.3
44 psychotic disorder 10.3
45 schizoaffective disorder 10.3
46 paranoid schizophrenia 10.3
47 myotonia 10.3
48 alcohol dependence 10.3
49 tardive dyskinesia 10.3
50 obsessive-compulsive disorder 10.3

Graphical network of the top 20 diseases related to Major Affective Disorder 2:



Diseases related to Major Affective Disorder 2

Symptoms & Phenotypes for Major Affective Disorder 2

Human phenotypes related to Major Affective Disorder 2:

32
# Description HPO Frequency HPO Source Accession
1 bipolar affective disorder 32 HP:0007302

Symptoms via clinical synopsis from OMIM:

57
Neuro:
bipolar affective disorder

Misc:
early onset (before 30 years of age)

Clinical features from OMIM:

309200

Drugs & Therapeutics for Major Affective Disorder 2

Drugs for Major Affective Disorder 2 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 457)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Paroxetine Approved, Investigational Phase 4 61869-08-7 43815
2
Sertraline Approved Phase 4 79617-96-2 68617
3
Reboxetine Approved, Experimental Phase 4 98769-81-4, 71620-89-8 123628 65856
4
Topiramate Approved Phase 4 97240-79-4 5284627
5
Tranylcypromine Approved, Investigational Phase 4 155-09-9 441233
6
Risperidone Approved, Investigational Phase 4 106266-06-2 5073
7
Galantamine Approved Phase 4 357-70-0 9651
8
Ropinirole Approved, Investigational Phase 4 91374-21-9, 91374-20-8 5095 497540
9
Memantine Approved, Investigational Phase 4 19982-08-2 4054
10
Naltrexone Approved, Investigational, Vet_approved Phase 4 16590-41-3 5360515
11
Cocaine Approved, Illicit Phase 4 50-36-2 446220 5760
12
Acamprosate Approved, Investigational Phase 4 77337-76-9 71158
13
Levetiracetam Approved, Investigational Phase 4 102767-28-2 441341
14
Minocycline Approved, Investigational Phase 4 10118-90-8 5281021
15
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
16
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
17
Norepinephrine Approved Phase 4 51-41-2 439260
18
Nortriptyline Approved Phase 4 72-69-5 4543
19
Exenatide Approved, Investigational Phase 4 141758-74-9 15991534
20
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
21
Mirtazapine Approved Phase 4 61337-67-5, 85650-52-8 4205
22
Histamine Approved, Investigational Phase 4 51-45-6 774
23
Ondansetron Approved Phase 4 99614-02-5 4595
24
Iloperidone Approved Phase 4 133454-47-4 71360
25
Brexpiprazole Approved, Investigational Phase 4 913611-97-9 11978813
26
Methohexital Approved Phase 4 151-83-7 9034
27
Dipyridamole Approved Phase 4 58-32-2 3108
28
Chlorpromazine Approved, Investigational, Vet_approved Phase 4 50-53-3 2726
29
Phenytoin Approved, Vet_approved Phase 4 57-41-0 1775
30
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
31
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
32
Methylphenidate Approved, Investigational Phase 4 113-45-1 4158
33
Metformin Approved Phase 4 657-24-9 4091 14219
34
Racepinephrine Approved Phase 4 329-65-7 838
35
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
36
Simvastatin Approved Phase 4 79902-63-9 54454
37
Methylcobalamin Approved, Experimental, Investigational Phase 4 13422-55-4
38
Hydroxocobalamin Approved Phase 4 13422-51-0 11953898 15589840
39
Amphetamine Approved, Illicit, Investigational Phase 4 300-62-9 5826 3007
40
Dextroamphetamine Approved, Illicit Phase 4 51-64-9 5826
41
Acetaminophen Approved Phase 4 103-90-2 1983
42
Angiotensin II Approved, Investigational Phase 4 11128-99-7, 68521-88-0, 4474-91-3 172198
43
Losartan Approved Phase 4 114798-26-4 3961
44
Loxapine Approved Phase 4 1977-10-2 3964
45
Bromocriptine Approved, Investigational Phase 4 25614-03-3 31101
46
Eleuthero Approved, Experimental Phase 4
47
Oxcarbazepine Approved Phase 4 28721-07-5 34312
48
Clozapine Approved Phase 4 5786-21-0 2818
49
Nicotine Approved Phase 4 54-11-5 942 89594
50
Promethazine Approved, Investigational Phase 4 60-87-7 4927

Interventional clinical trials:

(show top 50) (show all 1441)
# Name Status NCT ID Phase Drugs
1 An Open Label, Multicenter, Single Arm, 4-Week Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder Unknown status NCT00837343 Phase 4 quetiapine fumarate tablet (Seroquel)
2 Effects of N-Acetyl-Cysteine on Oxidative Stress Biomarkers in Bipolar Patients With and Without Tobacco Use Disorder Unknown status NCT02252341 Phase 4
3 Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder Unknown status NCT00608075 Phase 4 lithium;Lithium
4 Exploring Alterations of Central Autonomic Modulation in Patients With Bipolar Depression Unknown status NCT01213121 Phase 4 Quetiapine
5 A Randomized, Double-blind, Placebo-controlled Study of Quetiapine SR and Divalproex Sodium ER on Anxiety in Bipolar Disorder With at Least Moderately Severe Current Anxiety and Lifetime Panic or Generalized Anxiety Disorder. Unknown status NCT00579280 Phase 4 quetiapine SR;divalproex sodium ER;placebo
6 Assessing the Efficacy of Left Repetitive Transcranial Magnetic Stimulation (rTMS) as an Adjunctive Treatment to Mood Stabilizers for the Treatment of Bipolar Depression Unknown status NCT01583023 Phase 4 Bupropion
7 Assessment and Follow Up Study of Children and Adolescent With Bipolar Disorder Unknown status NCT01000402 Phase 4 Psychopharmacotherapy
8 A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar I and II Depression. Unknown status NCT00335205 Phase 4 ropinirole
9 Clinical Psychopharmacology Division Institute of Mental Health, Peking University Unknown status NCT03148535 Phase 4 Lithium Carbonate;lithium carbonate combined with SSRI antidepressant treatment
10 A Randomized Open-label Active-controlled Study to Evaluate the Efficacy and Safety of Utapine Versus Seroquel in Patients With Bipolar Mania Unknown status NCT01043679 Phase 4 Utapine;Seroquel
11 Comparative Efficacy and Acceptability of Lithium, Valproate, Oxcarbazepine, Quetiapine, Olanzapine, and Ziprasidone in Bipolar I Disorder, Manic or Mixed Phase Unknown status NCT01893229 Phase 4 Lithium;Valproate;Oxcarbazepine;Quetiapine;Olanzapine;Ziprasidone
12 Open Label Prophylaxis Study of Lithium Plus Extended- Release Carbamazepine (Equetro®) Combination for Rapid Cycling Bipolar Disorder Unknown status NCT00325286 Phase 4 Lithium Plus Extended- Release Carbamazepine
13 Reduction of Cardiovascular Risk in Severe Mental Illness Prescribing and Using Better and More Appropriated Drugs Unknown status NCT01182012 Phase 4
14 Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in PCOS Patients. Unknown status NCT01246310 Phase 4
15 Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia by Aripiprazole Add-on Therapy in the Treatment of Schizophrenia and Bipolar Disorder: An Open-Label Trial Unknown status NCT00541554 Phase 4 Abilify (aripiprazole)
16 Phase 3 Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study Unknown status NCT00426946 Phase 4 Reboxetine
17 The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope Unknown status NCT01357967 Phase 4 SSRI monotherapy;Seroquel XR adjunctive
18 Aripiprazole in Late Life Bipolar Disorder Completed NCT00194038 Phase 4 Aripiprazole
19 Add-on Valproate in Late Life Schizophrenia Completed NCT00194025 Phase 4 Valproate
20 A Randomized, Open-label, Trial of Lithium Versus Paroxetine in Subjects With Major Depression Who Have a Family History of Bipolar Disorder or Completed Suicide Completed NCT01416220 Phase 4 Lithium;Paroxetine
21 A Randomized, Sham Controlled, Crossover Trial of rTMS for Bipolar Depression Completed NCT00186758 Phase 4
22 Comparison of Propofol Target-Controlled Infusion Anesthesia and Bolus Injection in Electroconvulsive Therapy: A Randomized Controlled Trial Completed NCT03863925 Phase 4
23 Lamictal for Use in Treatment of Bipolar Disorder In Adults. A Practical Clinical Assessment of Tolerability and Clinical Effectiveness. Completed NCT00067938 Phase 4 lamotrigine
24 An Open-Label Extension Study to Assess the Safety of Lamotrigine in Subjects With Bipolar Disorder, Who Are in Remission Following a Manic/Hypomanic Index Episode or a Depressive Index Episode. Completed NCT00360126 Phase 4 lamotrigine
25 Lamictal As Add on Treatment in Mixed States of Bipolar Disorder Completed NCT00223509 Phase 4 Lamotrigine
26 Multi-center, Double-blind, Randomized, Comparative Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify and Depakote in 24-week Treatment of Mania in Patients With Bipolar Disorder Remitted After 6-week Treatment With Abilify and Depakote Completed NCT00545675 Phase 4 Abilify(aripiprazole);Depakote (divalproate)
27 Multi-center, Single Arm, Open Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify With Depakote in the 6-week Treatment of Acute Mania in Patients With Bipolar Disorder Completed NCT00545142 Phase 4 Abilify(Aripiprazole);Depakote(Divalproate)
28 Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder Completed NCT00050206 Phase 4 Olanzapine;Placebo
29 A 52-week, Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder Completed NCT00139594 Phase 4 licarbazepine
30 Adjunctive Ziprasidone in Overweight and Obese Patients With Bipolar Disorder Completed NCT00472641 Phase 4 Ziprasidone/Geodon
31 Quetiapine for Bipolar Disorder and Alcohol Dependence Completed NCT00457197 Phase 4 Placebo;Quetiapine
32 A Randomized, Double-Blind, Placebo Controlled Study Of Quetiapine SR (QTP) As Adjunctive Treatment In Mixed States (MS) Of Bipolar Disorder Completed NCT01195363 Phase 4 quetiapine SR;quetiapine sr placebo
33 A Randomized, Double-blind, Placebo-controlled Study of the Efficacy of Ropinirole in the Treatment of Depression in Bipolar Disorder Completed NCT00314821 Phase 4 ropinirole
34 Cognitive Enhancement in Bipolar Disorder Completed NCT00597896 Phase 4 pramipexole
35 Memantine and Cognitive Dysfunction in Bipolar Disorder Completed NCT00586066 Phase 4 Memantine;Placebo
36 A Study of Sertraline to Prevent PTSD Completed NCT00182078 Phase 4 Placebo;Sertraline
37 Olanzapine/Fluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression Completed NCT00485771 Phase 4 Olanzapine;Fluoxetine;Lamotrigine
38 Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study Completed NCT00477373 Phase 4 depakine chrono
39 Olanzapine Plus Carbamazepine Versus Carbamazepine Alone in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder Completed NCT00190892 Phase 4 olanzapine;carbamazepine
40 Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder, Manic or Mixed Completed NCT00034580 Phase 4 olanzapine;risperidone
41 Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder Completed NCT00572117 Phase 4 Topiramate
42 Tranylcypromine Treatment of Bipolar Depression Completed NCT01430455 Phase 4 Tranylcypromine
43 Depakote ER Therapy for Mania Comorbid With Substance Abuse Completed NCT00208195 Phase 4 Divalproex ER
44 A Phase IV STudy of the Effectiveness of Quetiapine Extended Release 600mg Once a Day to Control the Symptoms of Manic Phase of Bipolar Disorder. Completed NCT00521365 Phase 4 Quetiapine 600mg
45 A Double-Blind, Randomized, Placebo-Controlled Trial of Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder. Completed NCT00552760 Phase 4 Ramelteon;Placebo
46 A Double Blind, Randomized, Placebo Controlled Trial of Aripiprazole Plus Valproate in the Short-Term and Long-Term Treatment of Bipolar Disorder Completed NCT00484471 Phase 4 aripiprazole;valproate;placebo
47 A Phase 4 Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder Completed NCT00195845 Phase 4 Galantamine;Placebos
48 Olanzapine Versus Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated With Bipolar I Disorder Completed NCT00094549 Phase 4 olanzapine;divalproex sodium;placebo
49 A Double-Blind, Placebo-Controlled Trial of Lamotrigine In Individuals With Bipolar Disorder and Comorbid Alcohol Dependence Completed NCT01015586 Phase 4 Lamotrigine;Placebo
50 Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer And a Classic Mood Stabilizer for Bipolar Disorder Completed NCT01331304 Phase 4 Lithium;Quetiapine

Search NIH Clinical Center for Major Affective Disorder 2

Inferred drug relations via UMLS 72 / NDF-RT 51 :


Carbamazepine
Clonazepam
Clozapine
CLOZAPINE (CARACO)
CLOZAPINE (CLOZARIL)
CLOZAPINE (IVAX)
CLOZAPINE (TEVA)
CLOZAPINE (VERSACLOZ)
Divalproex Sodium
Fazaclo
gabapentin
gabapentin enacarbil
lamotrigine
Lithium
Lithium Aspartate
Lithium Carbonate
lithium citrate
Maprotiline
Mylan brand of clozapine
olanzapine
quetiapine
Quetiapine fumarate
Risperidone
Sodium Valproate
tiagabine
Tiagabine hydrochloride
topiramate
UDL brand of clozapine
Valproic Acid

Genetic Tests for Major Affective Disorder 2

Anatomical Context for Major Affective Disorder 2

MalaCards organs/tissues related to Major Affective Disorder 2:

41
Brain, Testes, Eye, Heart, Cortex, Prefrontal Cortex, Bone

Publications for Major Affective Disorder 2

Articles related to Major Affective Disorder 2:

(show top 50) (show all 52)
# Title Authors PMID Year
1
Manic depressive illness not linked to factor IX region in an independent series of pedigrees. 38 8
1980485 1990
2
Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor. 8
15452587 2005
3
Bipolar disorder and linkage to Xq28. 8
7951314 1994
4
Is bipolar disorder linked to Xq28? 8
8012380 1994
5
Behavioural disorders: lessons in linkage. 8
8490652 1993
6
Diminished support for linkage between manic depressive illness and X-chromosome markers in three Israeli pedigrees. 8
8490654 1993
7
A critical analysis of data presented in eight studies favouring X-linkage of bipolar illness with special emphasis on formal genetic aspects. 8
1487243 1992
8
A critical appraisal of X-linked bipolar illness. Evidence for the assumed mode of inheritance is lacking. 8
1544014 1992
9
Polymorphic DNA marker on X chromosome and manic depression. 8
2884369 1987
10
Genetic linkage between X-chromosome markers and bipolar affective illness. 8
3493438 1987
11
Assessing the role of X-linked inheritance in bipolar-related major affective disorder. 8
3806423 1986
12
A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. 8
7125846 1982
13
X-linkage in bipolar affective illness. Perspectives on genetic heterogeneity, pedigree analysis and the X-chromosome map. 8
6454708 1981
14
Familial patterns and possible modes of inheritance of primary affective disorders. 8
6454711 1981
15
Linkage between glucose-6-phosphate dehydrogenase deficiency and manic-depressive psychosis. 8
7448473 1980
16
Linkage between an X-chromosome marker (deutan color blindness) and bipolar affective illness. Occurrence in the family of a lithium carbonate-responsive schizo-affective proband. 8
301380 1977
17
A Danish twin study of manic-depressive disorders. 8
558030 1977
18
The inheritance of affective disorders: a review of data and of hypotheses. 8
1086088 1976
19
X-linkage in manic-depressive illness. 8
1096758 1975
20
Morbidity risk and genetic transmission in manic-depressive illness. 8
4548308 1974
21
X-linkage in manic-depressive illness. 8
4541867 1973
22
Evidence for X-linkage in the transmission of manic-depressive illness. 8
4539092 1972
23
Genetic history as a predictor of lithium response in manic-depressive illness. 8
4110088 1972
24
Family history studies: V. The genetics of mania. 8
5304735 1969
25
Possible role of X-linked dominant factor in manic depressive disease. 8
4975420 1969
26
The genealogy of major depression: symptoms and signs of melancholia from 1880 to 1900. 38
28785109 2017
27
[Cycloid psychoses as atypical manic-depressive disorders. Results of a family study]. 38
16502008 2006
28
Manic depressive illness in a founder population. 38
12891380 2003
29
[The concept of mood disorder in ICD-10]. 38
11519145 2001
30
Mood stabilizers regulate cytoprotective and mRNA-binding proteins in the brain: long-term effects on cell survival and transcript stability. 38
11343630 2001
31
Information processing deficits in relatives of manic depressive patients. 38
10883710 2000
32
Decreased serotonin transporter binding in unaffected relatives of manic depressive patients. 38
10624553 1999
33
Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness. 38
10622182 1999
34
Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. 38
10578449 1999
35
No association between dopamine D1, D2, and D3 receptor genes and manic-depressive illness. 38
9787891 1998
36
[Manic-depressive disease]. 38
9453187 1997
37
Manic depressive illness and tyrosine hydroxylase gene: linkage heterogeneity and association. 38
9440122 1997
38
Analysis of chromosome 18 DNA markers in multiplex pedigrees with manic depression. 38
8731455 1996
39
Search for a gene predisposing to manic-depression on chromosome 21. 38
7573177 1995
40
Mutation scan of the D1 dopamine receptor gene in 22 cases of bipolar I disorder. 38
7485250 1995
41
Manic-depressive illness and linkage reanalysis in the Xq27-Xq28 region of chromosome X. 38
7760986 1995
42
[Endocrinological examination and its clinical significance in manic-depressive illness]. 38
8007382 1994
43
Suggestion of linkage between manic-depressive illness and the enzyme phosphoglycolate phosphatase (PGP) on chromosome 16p. 38
8313623 1993
44
A genome-wide search for genes predisposing to manic-depression, assuming autosomal dominant inheritance. 38
8503452 1993
45
Minireview: Molecular genetics in affective illness. 38
8423707 1993
46
Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychoses? 38
2054147 1991
47
Inositol-1-phosphatase of human erythrocytes is inhibited by therapeutic lithium concentrations. 38
2540502 1989
48
Comparisons of psychopathological phenomena of 422 manic-depressive patients with suicide-positive and suicide-negative family history. 38
3389179 1988
49
[Family picture studies in patients with paranoid psychoses]. 38
6647888 1983
50
Psychiatric features of Huntington's disease: recent approaches and findings. 38
6232607 1983

Variations for Major Affective Disorder 2

Expression for Major Affective Disorder 2

Search GEO for disease gene expression data for Major Affective Disorder 2.

Pathways for Major Affective Disorder 2

GO Terms for Major Affective Disorder 2

Sources for Major Affective Disorder 2

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....